Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Region Hovedstadens forskningsportal Forside
Hjælp og OSS
Dansk
English
Forside
Hospitaler/afdelinger
Forskere
Publikationer
Aktiviteter
Priser
Søg efter ekspertise, navn eller tilknytning
In Vitro Angiogenesis Inhibition and Endothelial Cell Growth and Morphology
Arlinda Ljoki, Tanzila Aslam, Tina Friis, Ragnhild G Ohm,
Gunnar Houen
*
*
Corresponding author af dette arbejde
Afdeling for Hjerne- og Nervesygdomme
5
Citationer (Scopus)
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'In Vitro Angiogenesis Inhibition and Endothelial Cell Growth and Morphology'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Keyphrases
Cell Growth
100%
Human Umbilical Vein Endothelial Cells (HUVECs)
100%
Endothelial Cell Morphology
100%
Angiogenesis Inhibition
100%
In Vitro Angiogenesis
100%
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
50%
Glucocorticoid Receptor
16%
Cluster Formation
16%
Receptor Activation
16%
Avastin
16%
Cell Clusters
16%
Angiogenesis
16%
Area Cover
16%
Skin Fibroblasts
16%
Vascular Endothelial Growth Factor Receptor (VEGFR)
16%
Endothelial Differentiation
16%
Goat
16%
Angiogenesis Inhibitors
16%
N-methylation
16%
Sorafenib
16%
Co-culture Assay
16%
Network Formation
16%
Cluster Morphology
16%
EC Differentiation
16%
Vatalanib
16%
Nuclear Receptor Ligands
16%
VEGF Signaling Pathway
16%
Anti-VEGF Antibody
16%
Neutralizing Compounds
16%
Biochemistry, Genetics and Molecular Biology
Vascular Endothelial Growth Factor
100%
Cell Growth
100%
Antiangiogenic Activity
100%
Angiogenesis
50%
Normal Human
25%
Fibroblast
25%
Signal Transduction
25%
Cellular Differentiation
25%
Nuclear Receptor
25%
Coculture
25%
Bevacizumab
25%
Dexamethasone
25%
Sorafenib
25%
Glucocorticoid Receptor
25%
Vatalanib
25%
VEGF Signaling
25%
Immunology and Microbiology
Cell Growth
100%
Umbilical Vein Endothelial Cell
100%
Antiangiogenic Activity
100%
Vasculotropin
50%
Fibroblast
16%
Normal Human
16%
Dexamethasone
16%
Glucocorticoid
16%
Angiogenesis
16%
Cell Differentiation
16%
Signal Transduction
16%
Coculture
16%
Angiogenesis Inhibitor
16%
Bevacizumab
16%
Vasculotropin Antibody
16%
Vatalanib
16%
Sorafenib
16%
VEGF Signaling
16%
Pharmacology, Toxicology and Pharmaceutical Science
Vasculotropin
100%
Dexamethasone
25%
Normal Human
25%
Angiogenesis Inhibitor
25%
Bevacizumab
25%
Glucocorticoid Receptor
25%
Cell Nucleus Receptor
25%
Sorafenib
25%
Vasculotropin Antibody
25%
Vatalanib
25%